Ataxia and Seizure as a Manifestation in a Pediatric Case of SARS-CoV-2
Farzad Ahmadabadi, Amirmohammad Abdolmohammadzadeh, Negin Nahanmoghaddam, Faramarz Ajri
Asian Journal of Case Reports in Medicine and Health · pp. 99–104 · Published 7 Aug 2020
Abstract
Background: SARS-CoV-2 infection is an ongoing pandemic with more than seven million cases worldwide and a wide range of presenting symptoms in various ages. Neurological symptoms as mildly as a light headache and as severe as an acute encephalitis are reported. Objective: We aim to report the clinical course of pediatric patient infected with SARS-CoV-2 whom also presented ataxia and seizures as her neurological manifestation. Case: Patient was a 16 month old baby girl with clinical presentations of ataxia, focal myoclonic seizures, fever and diarrhea and no significant medical history. Her seizures were controlled with sodium valproate along with carnitine. She developed respiratory symptoms after her RT-PCR test from her nasopharyngeal sample swap returned with positive results. We ruled out a wide range of disease such as paraneoplastic and metabolic disorders. Patient was discharged with full recovery after receiving IVIG. Discussion: We believe there is a post infectious mechanism involved that has lead the patient to have such neurological manifestations because of a significant response to IVIG while she also presented typical finds in children infected with SARS-CoV-2. Patients with SARS-CoV-2 infection can have neurological manifestations despite their negative RT-PCR test for SARS-CoV-2 in their cerebrospinal fluid. Conclusion: During the pandemic, every practitioner should have SARS-CoV-2 infection in mind when it comes to neurological manifestations without a strongly-associated explanation.
Cited by 0
No indexed citations yet.
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.